Researchers identified a mutation in the WNT9B gene linked to significantly higher prostate cancer risk. Studies across multiple populations confirmed this finding, marking it as a major genetic risk factor alongside other established high-risk genes.
The discovery underscores (once more!) the importance of genetic screening for informed treatment and family risk assessment!